Cell No. : Cell Name
HPS0383 : CiRA00111
update : 2024/04/12
|
| Comment | Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (deletion of exon 44, dystrophin gene). HPS0384, HPS0385, HPS0386 and HPS0387 were derived from the same patient. Cryopreserved by vitrification method. |
| Comment from the depositor | |
| Terms and conditions | 1) The BIOLOGICAL RESOURCE must be used for academic research purpose conducted by RECIPIENT who belongs to a not-for profit academic organization (i.e. a university or another institution of higher education or any non-profit scientific or educational organization, including government agencies) . 2) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 3) Contact Us : RIKEN Cell Bank |
| Remarks | |
| Order Form |
Order Form(C-0042.pdf)
Approval Form(C-0057.pdf)
MTA(C-0007.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
https://www.cira.kyoto-u.ac.jp/
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Male
|
| Age at sampling |
1-9 years
|
| Tissue |
skin
|
| Disease name |
Muscular dystrophy, Duchenne type
|
| Classification |
iPS
|
| Recombinant |
recombinant
|
| Exogene |
Oct3/4, Sox2, Klf4, L-Myc, Lin28, p53 shRNA
|
| Vector |
pCXLE-hOct3/4-SHP53-F, pCXLE-hSK, pCXLE-hUL
|
|
Lifespan |
infinite
|
| Morphology |
ES-like
|
| Cellosaurus(Expasy) |
CVCL_VM71
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
DMEM/HamF12 (2.5mM GlutaMAX) + 2mM L-Glutamine + 20% KSR + 0.1mM NEAA + 0.1mM 2-Mercaptoethanol + 10ng/ml human basic FGF
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin + 0.1% collagenase type IV + 20% KSR + 1mM CaCl2 + PBS(-)
|
| Coating dish |
|
0.1% gelatin coated dish
|
Culture information
|
Passage ratio |
|
1 : 2-4 split
|
| SC frequency |
|
Subculture : once/4-6 days, Medium Renewal : every day
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Feeder cells |
|
SNL 76/7
|
| Feeder treatment |
|
X-rays 5000R (or MMC)
|
| Feeder seed cells |
|
1.5-2.5 x 10 6 cells/100 mm dish
|
| Freeze medium |
|
DAP213 : Medium + 2M DMSO + 1M Acetamide + 3M Propyleneglycol
|
| Freezing method |
|
Vitrification
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Relational File |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
4
|
| User's Publication |
0
|
| Reference |
|
13845
Minas Nalbandian, Mingming Zhao, Mitsuru Sasaki-Honda, Tatsuya Jonouchi, Antonio Lucena-Cacace, Takuma Mizusawa, Masahiko Yasuda, Yoshinori Yoshida, Akitsu Hotta, Hidetoshi Sakurai
Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy
Stem Cell Reports
2021
16(4):883-898
PubMed ID: 33798449
DOI: 10.1016/j.stemcr.2021.03.004
|
|
20473
Kenjo E, Hozumi H, Makita Y, Iwabuchi KA, Fujimoto N, Matsumoto S, Kimura M, Amano Y, Ifuku M, Naoe Y, Inukai N, Hotta A.
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice.
Nat Commun
2021
12(1):7101
PubMed ID: 34880218
DOI: 10.1038/s41467-021-26714-w
|
|
4015
Ifuku M, Iwabuchi KA, Tanaka M, Lung MSY, Hotta A.
Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.
Methods Mol Biol
2018
1828:191-217
PubMed ID: 30171543
DOI: 10.1007/978-1-4939-8651-4_12
|
|
4007
Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H, Yamamoto T, Yamanaka S, Hotta A.
Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Stem Cell Reports
2015
4:143-54
PubMed ID: 25434822
DOI: 10.1016/j.stemcr.2014.10.013
|
Back
Top
CELL BANK Website
SDS_DAP(MEM)_Japanese.pdf